Levy Y, George J, Yona E, Shoenfeld Y
Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Immunol Res. 1998 Aug;18(1):55-60. doi: 10.1007/BF02786513.
Partial lypodistrophy (PLD) is a rare disease in which, there is loss of fat usually from the upper part of the body. The disease is frequently associated with mesangiocapillary (membranoproliferative) glomerulonephritis Type II (MCGN II). In the early 1970s, it was noticed that MCGN II and/or PLD was sometimes associated with dysfunction of the complement system as reported in several case descriptions and studies. Subsequently, an IgG autoantibody was detected-C3 nephritic factor (C3NeF). The target of this autoantibody is the alternative pathway C3 convertase-C3bBb. There are sporadic case reports that linked PLD, MCGNII, and C3NeF with autoimmune diseases. This association may be more than a coincidence. The complement deficiency may lead to perturbation of the immune system, which may trigger some of the autoimmune diseases. This article will be focused on the association among PLD, MCGN II and C3NeF.
部分脂肪营养不良(PLD)是一种罕见疾病,其特征通常是身体上部脂肪流失。该疾病常与II型系膜毛细血管性(膜增生性)肾小球肾炎(MCGN II)相关。在20世纪70年代早期,正如一些病例描述和研究中所报道的,人们注意到MCGN II和/或PLD有时与补体系统功能障碍有关。随后,检测到一种IgG自身抗体——C3肾炎因子(C3NeF)。这种自身抗体的靶标是替代途径C3转化酶——C3bBb。有零星的病例报告将PLD、MCGNII和C3NeF与自身免疫性疾病联系起来。这种关联可能并非巧合。补体缺陷可能导致免疫系统紊乱,进而引发一些自身免疫性疾病。本文将聚焦于PLD、MCGN II和C3NeF之间的关联。